Literature DB >> 12736258

X-ray crystal structure of the liver X receptor beta ligand binding domain: regulation by a histidine-tryptophan switch.

Shawn Williams1, Randy K Bledsoe, Jon L Collins, Sharon Boggs, Millard H Lambert, Ann B Miller, John Moore, David D McKee, Linda Moore, Jason Nichols, Derek Parks, Mike Watson, Bruce Wisely, Timothy M Willson.   

Abstract

The x-ray crystal structures of the human liver X receptor beta ligand binding domain complexed to sterol and nonsterol agonists revealed a perpendicular histidinetryptophan switch that holds the receptor in its active conformation. Hydrogen bonding interactions with the ligand act to position the His-435 imidazole ring against the Trp-457 indole ring, allowing an electrostatic interaction that holds the AF2 helix in the active position. The neutral oxysterol 24(S),25-epoxycholesterol accepts a hydrogen bond from His-435 that positions the imidazole ring of the histidine above the pyrrole ring of the tryptophan. In contrast, the acidic T0901317 hydroxyl group makes a shorter hydrogen bond with His-435 that pulls the imidazole over the electron-rich benzene ring of the tryptophan, possibly strengthening the electrostatic interaction. Point mutagenesis of Trp-457 supports the observation that the ligand-histidine-tryptophan coupling is different between the two ligands. The lipophilic liver X receptor ligand-binding pocket is larger than the corresponding steroid hormone receptors, which allows T0901317 to adopt two distinct conformations. These results provide a molecular basis for liver X receptor activation by a wide range of endogenous neutral and acidic ligands.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12736258     DOI: 10.1074/jbc.M302260200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Structural basis for a molecular allosteric control mechanism of cofactor binding to nuclear receptors.

Authors:  Judit Osz; Yann Brélivet; Carole Peluso-Iltis; Vincent Cura; Sylvia Eiler; Marc Ruff; William Bourguet; Natacha Rochel; Dino Moras
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-21       Impact factor: 11.205

Review 2.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

Review 3.  Structural and functional insights into nuclear receptor signaling.

Authors:  Lihua Jin; Yong Li
Journal:  Adv Drug Deliv Rev       Date:  2010-08-17       Impact factor: 15.470

4.  Multiple-step virtual screening using VSM-G: overview and validation of fast geometrical matching enrichment.

Authors:  Alexandre Beautrait; Vincent Leroux; Matthieu Chavent; Léo Ghemtio; Marie-Dominique Devignes; Malika Smaïl-Tabbone; Wensheng Cai; Xuegang Shao; Gilles Moreau; Peter Bladon; Jianhua Yao; Bernard Maigret
Journal:  J Mol Model       Date:  2008-01-03       Impact factor: 1.810

5.  A functionally orthogonal ligand-receptor pair created by targeting the allosteric mechanism of the thyroid hormone receptor.

Authors:  A Quamrul Hassan; John T Koh
Journal:  J Am Chem Soc       Date:  2006-07-12       Impact factor: 15.419

6.  Structural basis of digoxin that antagonizes RORgamma t receptor activity and suppresses Th17 cell differentiation and interleukin (IL)-17 production.

Authors:  Saori Fujita-Sato; Shuichiro Ito; Takashi Isobe; Takao Ohyama; Kenji Wakabayashi; Kaoru Morishita; Osamu Ando; Fujio Isono
Journal:  J Biol Chem       Date:  2011-07-06       Impact factor: 5.157

Review 7.  Hypercholesterolemia links hematopoiesis with atherosclerosis.

Authors:  Oliver Soehnlein; Filip K Swirski
Journal:  Trends Endocrinol Metab       Date:  2012-12-08       Impact factor: 12.015

8.  Styrylphenylphthalimides as Novel Transrepression-Selective Liver X Receptor (LXR) Modulators.

Authors:  Sayaka Nomura; Kaori Endo-Umeda; Atsushi Aoyama; Makoto Makishima; Yuichi Hashimoto; Minoru Ishikawa
Journal:  ACS Med Chem Lett       Date:  2015-07-13       Impact factor: 4.345

Review 9.  PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1.

Authors:  Amin Majdalawieh; Hyo-Sung Ro
Journal:  Nucl Recept Signal       Date:  2010-04-16

10.  Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose.

Authors:  Elin Holter Anthonisen; Lise Berven; Sverre Holm; Maria Nygård; Hilde I Nebb; Line M Grønning-Wang
Journal:  J Biol Chem       Date:  2009-11-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.